Similar articles

• Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia.

  Van Herendael H, Dorian P. Van Herendael H, et al. Vasc Health Risk Manag. 2010 Aug 9;6:465-72. doi: 10.2147/vhrm.s6611. Vasc Health Risk Manag. 2010. PMID: 20730062 Free PMC article. Review.
• Amiodarone for ventricular tachycardia after coronary artery bypass grafting.

  Wood MK. Wood MK. Ann Thorac Surg. 1996 Jun;61(6):1874. doi: 10.1016/0003-4975(96)80210-4. Ann Thorac Surg. 1996. PMID: 8651814 No abstract available.
• Clinical utility and adverse effects of amiodarone therapy.

  Roberts M. Roberts M. AACN Adv Crit Care. 2010 Oct-Dec;21(4):333-8; quiz 339-40. doi: 10.1097/NCI.0b013e3181ef86fe. AACN Adv Crit Care. 2010. PMID: 21045568 No abstract available.
• An overview of antiarrhythmic drug management of electrical storm.

  Kowey PR. Kowey PR. Can J Cardiol. 1996 Apr;12 Suppl B:3B-8B; discussion 27B-28B. Can J Cardiol. 1996. PMID: 8616726 Review.
• Proarrhythmic potential of amiodarone: an underestimated risk?

  Jurado Román A, Rubio Alonso B, Martín Asenjo R, Salguero Bodes R, López Gil M, Arribas Ynsaurriaga F. Jurado Román A, et al. Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):292-4. doi: 10.1016/j.recesp.2011.05.014. Epub 2011 Aug 2. Rev Esp Cardiol (Engl Ed). 2012. PMID: 21813228 English, Spanish. No abstract available.